Arkolith/Insider Trading/AVEO/Form 4

Bailey Michael P

President & CEO, DirectorAVEO PHARMACEUTICALS, INC. (AVEO) · full profile →Form 4 · filed Dec 22, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
3 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 20, 2022Option exercise(M)26K$6.20$164K83K
Dec 20, 2022Option exercise(M)86K$5.60$480K176K
Dec 20, 2022Option exercise(M)165K$3.67$604K340K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 20, 2022Option exercise(M)26K—$094K
Dec 20, 2022Option exercise(M)86K—$035K
Dec 20, 2022Option exercise(M)165K—$0625K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-22-032490) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML